Abpro (NASDAQ:ABP) Stock Price Down 5.2% – Should You Sell?

Abpro Co. (NASDAQ:ABP) fell 5.2% during mid-day trading on Wednesday . The company traded as low as $0.25 and last traded at $0.26. 219,326 shares changed hands during mid-day trading, an increase of 156% from the average session volume of 85,565 shares. The stock had previously closed at $0.27.

Analyst Upgrades and Downgrades

Separately, Maxim Group initiated coverage on Abpro in a report on Monday, February 24th. They set a “buy” rating and a $4.00 price objective on the stock.

Abpro Stock Down 5.2 %

The company’s 50 day simple moving average is $0.62.

Institutional Investors Weigh In On Abpro

Several large investors have recently modified their holdings of ABP. Jane Street Group LLC bought a new position in shares of Abpro during the fourth quarter valued at approximately $37,000. Geode Capital Management LLC purchased a new stake in Abpro during the fourth quarter worth $53,000. LMR Partners LLP bought a new stake in Abpro during the 4th quarter valued at $112,000. AQR Arbitrage LLC purchased a new position in shares of Abpro in the 4th quarter valued at $157,000. Finally, Atlas Merchant Capital LLC bought a new position in shares of Abpro in the 4th quarter worth $157,000. Institutional investors own 23.30% of the company’s stock.

Abpro Company Profile

Abpro Holdings Inc is a biotechnology company. The company’s mission is to improve the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies. Abpro Holdings Inc, formerly known as Atlantic Coastal Acquisition Corp. II, is based in WOBURN, Mass.